Anti-inflammatory potential of probiotics: Lipoteichoic acid makes a difference

Trends in Microbiology

Volumn 20, Issue 1, 2012, Pages 5-10

  Lebeer, Sarah ^a,b   Claes, Ingmar J J ^a   Vanderleyden, Jos ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOTEICHOIC ACID; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; BIFIDOBACTERIUM; CHEMICAL STRUCTURE; CYTOKINE RELEASE; DENDRITIC CELL; ENTERITIS; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS; COLITIS; HUMANS; LACTOBACILLUS; LIPOPOLYSACCHARIDES; PROBIOTICS; STRUCTURE-ACTIVITY RELATIONSHIP; TEICHOIC ACIDS;

ANIMALIA; LACTOBACILLUS;

EID: 84855479943     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.09.004     Document Type: Review

References (55)

1. Minocha A. Probiotics for preventive health. Nutr. Clin. Pract. 2009, 24:227-241.
2. Mohamadzadeh M., et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4623-4630.
3. Grangette C., et al. Enhanced anti inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10321-10326.
4. Claes I.J.J., et al. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin. Exp. Immunol. 2010, 162:306-314.
5. Yan F., et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism J. Clin. Invest. 2011, 121:2242-2253.
6. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
7. Lebeer S., et al. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 2010, 8:171-184.
8. Konstantinov S.R., et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19474-19479.
9. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 2002, 347:417-429.
10. Neuhaus F.C., Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 2003, 67:686-723.
11. Duncker S.C., et al. The D-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model. Neurogastroenterol. Motil. 2008, 20:843-850.
12. Mileti E., et al. Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE 2009, 4:e7056.
13. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2002, 2:171-179.
14. Erridge C., et al. Structure and function of lipopolysaccharides. Microbes Infect. 2002, 4:837-851.
15. Nilsen N.J., et al. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling; role of CD14 and CD36. J. Leuk. Biol. 2008, 84:280-291.
16. Greenberg J.W., et al. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect. Immun. 1996, 64:3318-3325.
17. Lemjabbar H., Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nature Med. 2002, 8:41-46.
18. Weidenmaier C., Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 2008, 6:276-287.
19. Reichmann N.T., Grundling A. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. FEMS Microbiol. Lett. 2011, 319:97-105.
20. Schmidt R.R., et al. Chemical synthesis of bacterial lipoteichoic acids: an insight on its biological significance. Org. Biomol. Chem. 2011, 9:2040-2052.
21. Stadelmaier A., et al. Synthesis of the first fully active lipoteichoic acid. Angew Chem. Int. Ed. Engl. 2003, 42:916-920.
22. Deininger S., et al. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 2003, 170:4134-4138.
23. Baddiley J., Davison A.L. The occurrence and location of teichoic acids in lactobacilli. J. Gen. Microbiol. 1961, 24:295-299.
24. Matsuguchi T., et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through toll-like receptor 2. Clin. Diagn. Lab. Immunol. 2003, 10:259-266.
25. Palumbo E., et al. D-Alanyl ester depletion of teichoic acids in Lactobacillus plantarum results in a major modification of lipoteichoic acid composition and cell wall perforations at the septum mediated by the Acm2 autolysin. J. Bacteriol. 2006, 188:3709-3715.
26. Fischer K., et al. Cytokine-inducing lipoteichoic acids of the allergy-protective bacterium Lactococcus lactis G121 do not activate via Toll-like receptor 2. Glycobiology 2011, 21:1588-1595.
27. Ryu Y.H., et al. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 2009, 9:127-133.
28. Kim H.G., et al. Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumor necrosis factor-alpha production. J. Microbiol. Biotechnol. 2008, 18:1191-1196.
29. Kim H.G., et al. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J. Immunol. 2008, 180:2553-2561.
30. Kim H.G., et al. Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation. Mol. Immunol. 2011, 48:382-391.
31. Jang K.S., et al. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem. Biophys. Res. Commun. 2011, 407:823-830.
32. Tap J., et al. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 2009, 11:2574-2584.
33. Walter J. The ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl. Environ. Microbiol. 2008, 74:4985-4996.
34. Sansonetti P.J. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal. Immunol. 2011, 4:8-14.
35. Melmed G., et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 2003, 170:1406-1415.
36. Otte J.M., et al. Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004, 126:1054-1070.
37. Lotz M., et al. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 2006, 203:973-984.
38. Jin M.S., et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.
39. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 2010, 10:159-169.
40. Seo H.S., et al. Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid. Clin. Vaccine Immunol. 2006, 13:452-458.
41. Caplan M.S., et al. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr. Res. 1997, 42:779-783.
42. Bates J.M., et al. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007, 2:371-382.
43. Maudsdotter L., et al. Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid. Antimicrob. Agents Chemother. 2011, 55:1622-1628.
44. Underhill D.M., et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999, 401:811-815.
45. Perea Vélez M., et al. Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 2007, 73:3595-3604.
46. Saber R., et al. Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals. Immunotherapy 2011, 3:337-347.
47. Lebeer S., et al. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb. Biotechnol. 2010, 4:368-374.
48. Yasuda E., et al. Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides: their suppressive effect on the activation of macrophages. Appl. Environ. Microbiol. 2008, 74:4746-4755.
49. Ghadimi D., et al. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integrity of polarized intestinal epithelial cells. Inflamm. Bowel Dis. 2010, 16:410-427.
50. Rachmilewitz D., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
51. Claes I.J.J., et al. Lessons from probiotic-host interaction studies in murine models of experimental colitis. Mol. Nutr. Food Res. 2011, 55:1441-1453.
52. Iwasaki H., et al. Structure of macroamphiphiles from several Bifidobacterium strains. J. Bacteriol. 1990, 172:845-852.
53. Hart A.L., et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
54. Erridge C., et al. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J. Med. Microbiol. 2004, 53:735-740.
55. Coats S.R., et al. The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria. Infect. Immun. 2011, 79:203-210.